Capricor Therapeutics
CAPR
#7318
Rank
โ‚ฌ0.51 B
Marketcap
8,78ย โ‚ฌ
Share price
9.44%
Change (1 day)
82.24%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2023 (TTM): -1,11ย โ‚ฌ

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,18ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,05ย โ‚ฌ a decrease over its 2021 EPS that were of -0,78ย โ‚ฌ.

EPS history for Capricor Therapeutics from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,11ย โ‚ฌ5.16%
2022-1,05ย โ‚ฌ35.63%
2021-0,78ย โ‚ฌ-7.45%
2020-0,84ย โ‚ฌ-55.45%
2019-1,88ย โ‚ฌ-59.81%
2018-4,68ย โ‚ฌ-1850%
20170,27ย โ‚ฌ-102.94%
2016-9,09ย โ‚ฌ25.93%
2015-7,22ย โ‚ฌ55.77%
2014-4,63ย โ‚ฌ-39.53%
2013-7,66ย โ‚ฌ-64.78%
2012-21,76ย โ‚ฌ-62.44%
2011-57,92ย โ‚ฌ-31.58%
2010-84,65ย โ‚ฌ-38.71%
2009-138,12ย โ‚ฌ-43.64%
2008-245,05ย โ‚ฌ-5.17%
2007-258,42ย โ‚ฌ427.27%
2006-49,01ย โ‚ฌ340.33%
2005-11,13ย โ‚ฌ
2004N/A
2003N/A
2002N/A
2001N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
5,96ย โ‚ฌ-372.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
6,28ย โ‚ฌ-387.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-6,43ย โ‚ฌ 194.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,88ย โ‚ฌ 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-6,73ย โ‚ฌ 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-26,10ย โ‚ฌ 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA